Monocyte exposure to fine particulate matter results in miRNA release: A link between air pollution and potential clinical complication.

Humans Particulate Matter / toxicity MicroRNAs / genetics Monocytes Air Pollution / adverse effects Apoptosis Air Pollutants / toxicity
Civilization disorders Fine particulate matter MiRNA expression Monocytes

Journal

Environmental toxicology and pharmacology
ISSN: 1872-7077
Titre abrégé: Environ Toxicol Pharmacol
Pays: Netherlands
ID NLM: 9612020

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 25 04 2022
revised: 26 09 2022
accepted: 03 10 2022
pubmed: 14 10 2022
medline: 29 11 2022
entrez: 13 10 2022
Statut: ppublish

Résumé

Chronic exposure to PM

Identifiants

DOI: 10.1016/j.etap.2022.103996 PMID: 36228992
pubmed: 36228992
pii: S1382-6689(22)00189-2
doi: 10.1016/j.etap.2022.103996
pii:
doi:

Substances chimiques

Particulate Matter 0
MicroRNAs 0
Air Pollutants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103996

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ewa Konduracka (E)

Jagiellonian University Medical College, Coronary Disease Department and Heart Failure, John Paul II Hospital, Kraków, Poland. Electronic address: ekonduracka@interia.eu.

Krzysztof Krawczyk (K)

Jagiellonian University Medical College, Faculty of Health Sciences, Department of Emergency Medicine, Kraków, Poland.

Marcin Surmiak (M)

Jagiellonian University Medical College, 2nd Department of Internal Medicine, Kraków, Poland.

Maciej Pudełek (M)

Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland.

Krzysztof Piotr Malinowski (KP)

Jagiellonian University Medical College, Faculty of Medicine, Department of Bioinformatics and Telemedicine, Kraków, Poland.

Lucyna Mastalerz (L)

Jagiellonian University Medical College, 2nd Department of Internal Medicine, Kraków, Poland.

Mirosław Zimnoch (M)

AGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland; Max Planck Institute for Biogeochemistry in Jena, Hans-Knöll Jena, Germany.

Lucyna Samek (L)

AGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland; Max Planck Institute for Biogeochemistry in Jena, Hans-Knöll Jena, Germany.

Katarzyna Styszko (K)

AGH University of Science and Technology, Faculty of Energy and Fuels, Kraków, Poland.

Leszek Furman (L)

AGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland; Max Planck Institute for Biogeochemistry in Jena, Hans-Knöll Jena, Germany.

Michał Gałkowski (M)

AGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland; Max Planck Institute for Biogeochemistry in Jena, Hans-Knöll Jena, Germany; Department of Biogeochemical Signals, Max Planck Institute for Biogeochemistry, Hans-Knöll Str. 10, 07745 Jena, Germany.

Jadwiga Nessler (J)

Jagiellonian University Medical College, Coronary Disease Department and Heart Failure, John Paul II Hospital, Kraków, Poland.

Kazimierz Różański (K)

AGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland; Max Planck Institute for Biogeochemistry in Jena, Hans-Knöll Jena, Germany.

Marek Sanak (M)

Jagiellonian University Medical College, 2nd Department of Internal Medicine, Kraków, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Monocyte exposure to fine particulate matter...
questionsmedicales.fr › Mélanges complexes › Matière particulaire › Monocyte exposure to fine particulate matter...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN non traduit › Petit ARN non traduit › microARN › Monocyte exposure to fine particulate matter...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Phagocytes › Monocytes › Monocyte exposure to fine particulate matter...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pollution de l'environnement › Pollution de l'air › Monocyte exposure to fine particulate matter...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Mort cellulaire › Mort cellulaire régulée › Apoptose › Monocyte exposure to fine particulate matter...
questionsmedicales.fr › Actions chimiques et utilisations › Actions toxiques › Polluants environnementaux › Polluants atmosphériques › Monocyte exposure to fine particulate matter...